tirzepatide fda label Grants a New Indication for Obesity Management Tirzepatide (Mounjaro)-The new 'King Kong'
Description
Following a GLP-1 diet
Support for the Long Haul GLP-1 medications are just one piece of the puzzle
Microdosing semaglutide is a lower-dose approach to GLP-1 therapy that may help some patients achieve steady weight loss with potentially fewer side effects
Methods This was a single-center, retrospective cohort study involving adults with type 2 diabetes who received an escalated once-weekly semaglutide dose from 0.5 to 1.0 mg in routine clinical care
Book your discovery call with the link below Jones, DC
